Assessment of treatment satisfaction among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (tempo trial)

被引：0
|
作者：
Singh, A
Klareskog, L
van der Heijde, D
Pedersen, R
Wajdula, J
Fatenejad, S
机构：
[1] Wyeth Ayerst Res, GHOA, Collegeville, PA USA
[2] Karolinska Hosp, S-10401 Stockholm, Sweden
[3] Univ Hosp Maastricht, Maastricht, Netherlands
[4] Wyeth Ayerst Res, Clin Res, Collegeville, PA USA
[5] Wyeth Ayerst Res, Med Affairs, Collegeville, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] Assessment of treatment satisfaction among patients with active rheumatoid arthritis is a double-blind trial of etanercept and methotrexate alone and combined (tempo trial)
    Singh, A
    van der Heijde, D
    Klareskog, L
    Pedersen, R
    Fatenejad, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S695 - S695
  • [2] ASSESSMENT OF FUNCTIONAL STATUS AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS IN A DOUBLE-BLIND TRIAL OF ETANERCEPT AND METHOTREXATE, ALONE AND COMBINED (TEMPO TRIAL)
    van der Heijde, D.
    Klareskog, L.
    DeJager, J.
    Gough, A.
    Kalden, J.
    Malaise, M.
    Martin Mola, E.
    Pavelka, K.
    Sany, J.
    Settas, L.
    Wajdula, J.
    Fatenejad, S.
    Sanda, M.
    Pedersen, R.
    Singh, A.
    RHEUMATOLOGY, 2004, 43 : 36 - 37
  • [3] Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (tempo trial)
    Singh, A
    van der Heijde, D
    Klareskog, L
    Tornero, J
    Gomes, JM
    Radulescu, F
    Pedersen, R
    Wajdula, J
    Fatenejad, S
    Freundlich, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 76 - 76
  • [4] Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (TEMPO trial)
    van der Heijde, D
    Klareskog, L
    Pedersen, R
    Fatenejad, S
    Singh, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S514 - S514
  • [5] Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (year 3 tempo trial results)
    Van der Heijde, D
    Klareskog, L
    Pedersen, R
    Fatenejad, S
    Singh, A
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 408 - 408
  • [6] Radiographic outcomes of a double-blind study of etanercept and methotrexate, alone and combined, in patients with active rheumatoid arthritis (the Tempo Trial).
    van der Heijde, D
    Klareskog, L
    DeJager, J
    Gough, A
    Kalden, J
    Malaise, M
    Martin-Mola, E
    Pavelka, K
    Sany, J
    Settas, L
    Wajdula, J
    Pedersen, R
    Fatenejad, S
    Sanda, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S122 - S122
  • [7] Clinical outcomes of a double-blind study of etanercept and methotrexate, alone and combined, in patients with active rheumatoid arthritis (tempo trial), year 2 results
    Klareskog, L
    van der Heijde, D
    De Jager, J
    Kalden, J
    Malaise, M
    Gough, A
    Martin-Mola, E
    Pavelka, K
    Sany, J
    Settas, L
    Wajdula, J
    Pedersen, R
    Fatenejad, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 58 - 59
  • [8] DOUBLE-BLIND COMPARATIVE STUDY OF RADIOGRAPHIC PROGRESSION OF ETANERCEPT (E) AND METHOTREXATE (MTX), ALONE AND COMBINED (E plus MTX), IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (TEMPO TRIAL)
    van der Heijde, D.
    Klareskog, L.
    DeJager, J.
    Gough, A.
    Kalden, J.
    Malaise, M.
    Mola, E. Martin
    Pavelka, K.
    Sany, J.
    Settas, L.
    Wajdula, J.
    Pedersen, R.
    Fatenejad, S.
    Sanda, M.
    Singh, A.
    RHEUMATOLOGY, 2004, 43 : 37 - 37
  • [9] Results of patient-reported outcomes in a 3-year double-blind study of etanercept (Enbrel®) and methotrexate, alone and combined, in patients with active rheumatoid arthritis:: TEMPO trial
    Singh, A
    Kjareskog, L
    Pedersen, R
    Fatenejad, S
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S233 - S233
  • [10] Limiting radiographic damage is associated with restoration of normal functioning in patients with rheumatoid arthritis: Results from a double-blind trial of etanercept and methotrexate, alone and combined (TEMPO)
    Van der Heijde, D.
    Fatenejad, S.
    Freundlich, B.
    Sato, R.
    Singh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 604 - 604
12345